Your browser doesn't support javascript.
loading
Inhibition of the sodium-glucose co-transporter SGLT2 by canagliflozin ameliorates diet-induced obesity by increasing intra-adipose sympathetic innervation.
Yang, Xuping; Liu, Qinhui; Li, Yanping; Ding, Yi; Zhao, Yan; Tang, Qin; Wu, Tong; Chen, Lei; Pu, Shiyun; Cheng, Shihai; Zhang, Jinhang; Zhang, Zijing; Huang, Ya; Li, Rui; Zhao, Yingnan; Zou, Min; Shi, Xiongjie; Jiang, Wei; Wang, Rui; He, Jinhan.
Affiliation
  • Yang X; Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Liu Q; Department of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
  • Li Y; Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Ding Y; Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Zhao Y; Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Tang Q; College of Life Sciences, The Institute for Advanced Studies, Wuhan University, Wuhan, China.
  • Wu T; Department of Nuclear Medicine, Affiliated Hospital of Southwest Medical University, Luzhou, China.
  • Chen L; Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Pu S; Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Cheng S; Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Zhang J; Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Zhang Z; Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Huang Y; Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Li R; Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Zhao Y; Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Zou M; Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Shi X; Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Jiang W; Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Wang R; Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • He J; Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Br J Pharmacol ; 178(8): 1756-1771, 2021 04.
Article in En | MEDLINE | ID: mdl-33480065
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Canagliflozin / Positron Emission Tomography Computed Tomography Type of study: Etiology_studies Limits: Animals Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Canagliflozin / Positron Emission Tomography Computed Tomography Type of study: Etiology_studies Limits: Animals Language: En Year: 2021 Type: Article